Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Tocris Bioscience™ BAY 598
Potent and selective SMYD2 inhibitor
Supplier: Tocris Bioscience™ 5991/25
This item is not returnable.
View return policy
Description
BAY 598 is a potent and selective competitive inhibitor of SMYD2 lysine methyltransferase (IC50 values are 27 and 58 nM for biochemical and cellular activity assays, respectively), which displays >100-fold selectivity for SMYD2 over a panel of 32 other methyltransferases including SMYD3, SUV420H1, and SUV420H2. BAY 598 enhances apoptotic responses to doxorubicin (Cat. No. 2252) in cancer cell lines, and decreases p53K370me levels in HEK293 cells. It also reduces methylation in tumor cells in a mouse xenograft model.To request the negative control for BAY 598, please fill out the BAY 369 request form on the SGC website.
Specifications
| N-[(4 S)-1-[(Cyanoamino)[[3-(difluoromethoxy)phenyl]imino]methyl]-3-(3,4-dichlorophenyl)-4,5-dihydro-1 H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide | |
| 25 mg | |
| C22H20Cl2F2N6O3 | |
| 98% |
| 1906919-67-2 | |
| Additional Lysine Methyltransferase Compounds | |
| 525.34 |
Safety and Handling
Recommended Storage : Store at -20°C
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction